Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
U3 Pharma GmbH
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Pathologically or cytologically documented advanced solid tumor that is refractory to standard treatment, for which no standard therapy is available, or the patient refuses standard therapy.
Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2.
Men or women at least 18 years of age
Adequate hematologic, cardiac, renal, hepatic, metabolic, and coagulation function
You may not be if
Presence of untreated or symptomatic brain metastasis.
Presence of ascites or pleural effusion requiring chronic medical intervention.
Uncontrolled hypertension
Concurrent or previous (within 1 week of study day 1) anticoagulation therapy, except low-dose warfarin (≤ 2 mg/day) or low dose,low molecular weight heparin for prophylaxis against central venous catheter thrombosis.
Recent major surgical procedure or not yet recovered from major surgery
Recent participation in clinical drug trials.
Participation in other investigational procedures.
Unresolved toxicities from prior anti-cancer therapy
Patient who is pregnant (e.g. positive human choriogonadotropin \[HCG\] test) or nursing.
